BREAKTHROUGH NEURAL THERAPIES
We explore emerging therapeutic strategies and advanced molecular approaches to bring scientific progress closer to real treatment options for neurological disorders.
Where Neural Research Meets Real Impact
Neural Drug Research is an independent research group focused on evaluating emerging therapeutics for spinal cord injury. Our work bridges scientific rigor with clinical relevance to support evidence-based innovation.
Vision
To become a trusted reference centre for the scientific evaluation of neurological therapeutics and
to bridge the gap between academic research and clinical implementation.
Mission
- Conduct scientific assessments of novel spinal cord injury therapies
- Develop analytical tools and research frameworks
- Accelerate translation of scientific advances into clinical practice
Advancing neurological therapeutics through science
Scientific Insights & Research Updates
We curate and analyze recent research findings, therapeutic developments, and scientific insights to support informed progress in neurological treatment strategies.
Pharmacologic and Cellular Approaches in Spinal Cord Injury: A Critical Overview
Article reviewed:
Khalid SI et al. Pharmacologic and cellular therapies in the treatment of traumat...
New Approaches to Modulating CSPG Signaling After Spinal Cord Injury
A recent wave of studies is taking a closer look at how chondroitin sulfate proteoglycans (CSPGs) co...
A Glimpse on NVG-291 History
40 Years of Dr. Jerry Silver’s Groundbreaking Research Now Reaches SCI Patients
Dr. Jerry Silver’...
The Impact of Nicotine and Smoking on Spinal Cord Injury Recovery
Nicotine and smoking have long been linked to various negative health outcomes, but their effects on...
Psilocybin and Spinal Cord Injury (SCI)
Overview
Psilocybin is a naturally occurring compound found in certain mushrooms. When taken, the...
Thiorphan: Mechanism, Neuroprotective Effects, and Potential in Spinal Cord Injury and Brain Disorders
Thiorphan is a potent inhibitor of neutral endopeptidase (NEP), also known as CD10, neprilysin, and ...
NVG-291: Exploring Its Potential in Spinal Cord Injury and Neuroprotection
Introduction
NVG-291 is a promising experimental agent designed to address neuroinflammation, a key...
Therapeutic Directions
The biological complexity of spinal cord injury (SCI) makes it unlikely that a single intervention c...
Barriers to Repair – Spinal Cord Injury
Introduction
Repair in the central nervous system is profoundly limited. After spinal cord injury...
Biology of Injury – Spinal Cord Injury
Introduction
Spinal cord injury (SCI) sets off a complex series of biological events that extend ...